Clinical Trials for Immunosuppression in Transplantation
Philip J. O’Connell(The University of Sydney), Randall E. Morris(Novartis (Switzerland)), Peter Nickerson(Shared Services Canada), John S. Gill(University of British Columbia), Jesse D. Schold(Colorado School of Public Health), Minnie Sarwall(University of California, San Francisco), E. Steve Woodle(University of Cincinnati Medical Center), Daniel Serón(Vall d'Hebron Hospital Universitari), Dorry L. Segev(New York University), Stefan G. Tullius(Brigham and Women's Hospital), Dirk Kuypers(KU Leuven), Klemens Budde(Charité - Universitätsmedizin Berlin), Roslyn B. Mannon(University of Nebraska Medical Center), Jonathan S. Bromberg(University of Maryland, Baltimore), Christophe Legendre(Hôpital Necker-Enfants Malades), Mark D. Stegall(Mayo Clinic in Arizona), Germaine Wong(Children's Hospital at Westmead), Michaël Abécassis(University of Arizona), Stanley C. Jordan(Cedars-Sinai Medical Center), Peter G. Stock(University of California, San Francisco), Carmen Lefaucheur(Inserm), Stephen J. Chadban(Royal Prince Alfred Hospital), Rita R. Alloway(Northwestern University), Nancy Ascher(University of California, San Francisco), Barbara Murphy
Cited by 59
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k